Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium

Shimizu T.Kim D.-W.Loong H.H.CHIA-CHI LINNg M.C.H.Yamamoto N.Ma B.Tan D.S.W.2022-09-152022-09-1520211743-7555https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099931956&doi=10.1111%2fajco.13510&partnerID=40&md5=8024aee48008a3e89d0df7a0b23a58ebhttps://scholars.lib.ntu.edu.tw/handle/123456789/620216Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consortiumjournal article10.1111/ajco.13510335020852-s2.0-85099931956